Drug diversion is a serious concern in any pharmacy setting. In this interview with Beth Richter, Pharm.D., vice president of business development at Invistics, we’ll take a look at how artificial intelligence can analyze the many data points recorded within pharmacy technology systems to identify diversion faster and more accurately than traditional methods.
PTMR: Beth, tell us about what Invistics does.
Beth Richter: Invisitics has been around for 20 years. We actually started with the focus on supply chain management and logistics. What we then found is that this expertise was valuable for tackling the challenge of drug diversion too, controlled substances in particular.
PTMR: There’s a lot of risk to manage when it comes to controlled substances, right?
Richter: Yes. You are legally required to account fo…
Keep reading with a 7-day free trial
Subscribe to Pharmacy Technology & Management Review to keep reading this post and get 7 days of free access to the full post archives.